IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by IRADIMED CORPORATION on April 30, 2021. The report serves to announce the financial results for the first quarter ended March 31, 2021. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol IRMD.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the issuance of a press release containing the first-quarter results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 30, 2021) for actual Q1 2021 financial figures.
- Verify the specific revenue and net income numbers for the quarter ended March 31, 2021.
- Check for any updated guidance or outlook provided in the referenced press release.
- Confirm the status of the company's emerging growth company election as noted in the filing.